<DOC>
	<DOCNO>NCT02083809</DOCNO>
	<brief_summary>Currently , little research identify way decrease blood loss D &amp; E ( dilation evacuation ) procedure . The objective determine whether routine use intravenous oxytocin improve bleed outcome time D &amp; E 18-24-weeks gestation . To evaluate hypothesis , investigator perform randomize , double-blinded , placebo-controlled trial . The patient follow discharged postoperative care unit time patient satisfaction , pain score postoperative bleeding assess .</brief_summary>
	<brief_title>Effects Oxytocin Bleeding Outcomes During Dilation Evacuation</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Requesting pregnancy termination Intrauterine pregnancy 18 24weeks gestation Gestationalage confirm ultrasound Patients fetal anomaly intrauterine fetal demise occur 18 24weeks gestation Willing able understand sign write informed consent English Spanish comply study procedure Ultrasound finding suggestive placenta accreta Patients require preoperative misoprostol</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>